Researchers studying headband device for Alzheimer’s disease … Some older brains have changes in oxygen levels, neural activity … More than 2M people have inflammatory bowel disease … Feds release...
Quest launches consumer test for Alzheimer’s
By
Kristen Fischer
Aug 01, 2023
People can buy a blood test to check their levels of beta amyloid — a protein that’s known to contribute to Alzheimer’s disease. They can go directly to a Quest lab for bloodwork; the company’s...
Clinical briefs for Tuesday, August 1
By
Kristen Fischer
Aug 01, 2023
Vaccine for Alzheimer’s disease gets its start … Free online Parkinson’s course offers information for paid caregivers … Neurologists share tips for Alzheimer’s drugs … Eye experts offer safety...
Clinical briefs for Monday, July 31
By
Kristen Fischer
Jul 31, 2023
Light therapy may be the answer for Alzheimer’s ‘sundowning’ … These exercises can lower blood pressure … Gut health linked to inflammatory arthritis … The factors at play in emergency...
Report: About 1.4M people with dementia visit the ER each year
By
Kristen Fischer
Jul 28, 2023
Each year, there are almost 1.4 million emergency room (ER) visits for people with Alzheimer’s disease and related dementias (ADRDs), a new study found. Accidents and behavioral issues are the most common,...
Scent waning? This Alzheimer’s gene may be the culprit, study shows
By
Kristen Fischer
Jul 27, 2023
Sense of smell may be the first to go in people who carry a gene variant that’s linked to the highest risk for Alzheimer’s disease, according to a new study.
Alzheimer’s brain imaging research fails to adequately represent minority groups, major study finds
By
Kristen Fischer
Jul 26, 2023
A massive new study gives specifics into the lack of diversity in Alzheimer’s disease research.
Alzheimer’s diagnosis via a finger prick test? That could be coming soon
By
Kristen Fischer
Jul 20, 2023
Researchers say they’re one step closer to being able to diagnose Alzheimer’s disease using a finger prick blood test. The test has the potential to be used at home and reach more people, they...
A first: FDA approves drug to treat agitation in Alzheimer’s dementia
By
Alicia Lasek
May 12, 2023
For the first time, the FDA has approved a drug to treat agitation related to Alzheimer’s disease dementia. Patient advocates are hailing the news, but prescribing the drug, an antipsychotic, may put...
Medicare costs could rise by $5B annually with expanded Alzheimer’s drug coverage: study
By
Alicia Lasek
May 12, 2023
Medicare costs could rise by $2 to $5 billion a year if CMS expands its coverage for newly approved Alzheimer’s disease drug Leqembi (lecanemab), investigators say.